You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dasatinib

Showing 51 - 75 of 229
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in Worldwide (Dasatinib)

Completed
Has Results
  • Leukemia
  • Dasatinib
  • Vienna, Austria
  • +12 more
Feb 24, 2021

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Dasatinib
  • laboratory biomarker analysis
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Dec 14, 2020

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

Chronic Myeloid Leukemia Trial in New Zealand (Dasatinib, Imatinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Auckland, New Zealand
  • +8 more
Mar 10, 2021

Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Withdrawal;Drug
  • Imatinib withdrawal
  • +2 more
  • Brno, Czechia
  • +7 more
Aug 24, 2022

Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia Trial in Chicago (Inotuzumab ozogamicin,

Recruiting
  • Lymphoblastic Leukemia
  • +2 more
  • Inotuzumab ozogamicin
  • +7 more
  • Chicago, Illinois
    University of Chicago Medical Center
May 16, 2022

Solid Tumor Trial in Washington (ixabepilone, Dasatinib)

Completed
  • Solid Tumor
  • Washington, District of Columbia
    Washington Cancer Institute
Aug 3, 2020

Leukemia Trial in Houston (Dasatinib, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 29, 2020

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Dasatinib)

Withdrawn
  • Advanced Lymphoma
  • +5 more
  • Dasatinib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jul 17, 2020

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)

Active, not recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Boston, Massachusetts
  • +8 more
Nov 10, 2022

Pineoblastoma Trial in Regensburg (Temozolomide, Irinotecan, Dasatinib)

Completed
  • Pineoblastoma
  • Regensburg, Germany
    University Hospital of Regensburg
Jul 29, 2021

Cholangiocarcinoma Trial in Boston (Dasatinib)

Completed
Has Results
  • Cholangiocarcinoma
  • Dasatinib
  • Boston, Massachusetts
  • +1 more
Jul 20, 2020

Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Birmingham, Alabama
  • +25 more
Mar 4, 2022

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Cancer, Advanced Solid Tumors Trial in Amsterdam (Sunitinib, Sorafenib, Erlotinib)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Amsterdam, Netherlands
    VUMedical Center
Apr 14, 2021

Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in United States

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Alemtuzumab
  • +20 more
  • Palo Alto, California
  • +100 more
Aug 3, 2022

Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)

Terminated
  • Acute Lymphocytic Leukemia
  • Adult Lymphoblastic Lymphoma
  • La Jolla, California
  • +3 more
Apr 26, 2022

Breast Cancer Trial in Houston (Dasatinib, AZD6244)

Terminated
Has Results
  • Breast Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Relapsed AML, T(8;21), C-KIT Mutation Trial in Tianjin (Dasatinib)

Withdrawn
  • Relapsed AML
  • +2 more
  • Dasatinib
  • Tianjin, Tianjin, China
    HBDH
Mar 19, 2020

Non-Hodgkin's Lymphoma, Multiple, Mycosis Fungoides Trial in Detroit (Dasatinib)

Terminated
  • Non-Hodgkin's Lymphoma
  • +4 more
  • Dasatinib
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 12, 2020

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
Has Results
  • Leukemia
  • Dasatinib
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Chronic Myelogenous Leukemia, Ph1-Positive, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001 (varying

Withdrawn
  • Chronic Myelogenous Leukemia, Ph1-Positive
  • +2 more
  • BP1001 (varying dose)
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
May 26, 2020

Neuroblastoma Trial in United States (Ceritinib, dasatinib, sorafenib)

Recruiting
  • Neuroblastoma
  • Birmingham, Alabama
  • +23 more
Sep 26, 2022

Neuroblastoma Recurrent Trial in Regensburg (Dasatinib, Rapamycin, Irinotecan)

Completed
  • Neuroblastoma Recurrent
  • Dasatinib
  • +3 more
  • Regensburg, Germany
    University Hospital Regensburg, Department of Pediatric Hematolo
Oct 2, 2020